Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease

INTRODUCTION: Alzheimer's disease (AD) is associated with synapse loss. Souvenaid, containing the specific nutrient combination Fortasyn Connect, was designed to improve synapse formation and function. The NL-ENIGMA study explored the effect of Souvenaid on synapse function in early AD by asses...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (N Y)
Main Authors: Scheltens, Nienke M.E., Briels, Casper T., Yaqub, Maqsood, Barkhof, Frederik, Boellaard, Ronald, van der Flier, Wiesje M., Schwarte, Lothar A., Teunissen, Charlotte E., Attali, Amos, Broersen, Laus M., van Berckel, Bart N.M., Scheltens, Philip
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Featured Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804721/
https://ncbi.nlm.nih.gov/pubmed/31650005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.08.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados